Cerebrovascular lesions induce transient -amyloid deposition
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Previous clinical studies have documented a close relationship between cerebrovascular disease and risk of Alzheimer's disease. We examined possible mechanistic interactions through use of experimental stroke models in a transgenic mouse model of β-amyloid deposition (APPswe/PS1dE9). Following middle cerebral artery occlusion, we observed a rapid increase in amyloid plaque burden in the region surrounding the infarction. In human tissue samples, however, we were unable to detect a localized increase in amyloid burden adjacent to cerebral infarcts. To resolve this discrepancy, we generated cerebral microstrokes in amyloid precursor protein mouse models with the photosensitive dye Rose bengal, and monitored plaque formation in real time using multiphoton microscopy. We observed a striking increase in the number of new plaques and amyloid angiopathy in the area immediately surrounding the infarcted area; however, the effect was transient, potentially resolving the discord between mouse and human tissue. We did not detect changes in candidate proteins related to β-amyloid generation or degradation such as β-amyloid-converting enzyme, amyloid precursor protein, presenilin 1, neprylisin or insulin-degrading enzyme. Together, these results demonstrate that strokes can trigger accelerated amyloid deposition, most likely through interference with amyloid clearance pathways. Additionally, this study indicates that focal ischaemia provides an experimental paradigm in which to study the mechanisms of plaque seeding and growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cerebral ischemia promotes amyloid plaque formation (Garcia-Alloza et al., 2011; Kitaguchi et al., 2009; Okamoto et al., 2012)”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Garcia-Alloza et al., 2011
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 2×
“, 2004), plasma homocysteine (Seshadri et al., 2002), tobacco use (Ott et al.”
BackgroundDiabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Hofman, A., Ott, A., Breteler, M. M., Bots, M. L., Slooter, A. J., van Harskamp, F., van Duijn, C. N., Van Broeckhoven, C., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,062
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987 · cited 2×
“The increase in the amyloid burden was the result of the generation of new plaques, and not the growth of existing plaques in concordance with previous observations (Garcia-Alloza et al., 2006; Meyer-Luehmann et al., 2008).”
ResultSelf-citationMetabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Launer, L. J. (1995) · JAMA · doi:10.1001/jama.1995.03530230032026 · Cited by 908
American Journal of Human Genetics
(2005) · Encyclopedia of Statistical Sciences · doi:10.1002/0471667196.ess7082.pub2 · Cited by 874
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies
Jankowsky, J. L., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G., & Borchelt, D. R. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00067-3 · Cited by 746
Research works printed but not linked: 2
- 2007, 54, 721
- 2002, Neuropathology and applied neurobiology, 28, 149
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Panza, F., Lozupone, M., Logroscino, G., & Imbimbo, B. P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0116-6 · Cited by 965
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Self-citationRegulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
Claassen, J. A. H. R., Thijssen, D. H. J., Panerai, R. B., & Faraci, F. M. (2021) · Physiological Reviews · doi:10.1152/physrev.00022.2020 · Cited by 915
Post-Stroke Cognitive Impairment and Dementia
Rost, N. S., Brodtmann, A., Pase, M. P., van Veluw, S. J., Biffi, A., Duering, M., Hinman, J. D., & Dichgans, M. (2022) · Circulation Research · doi:10.1161/circresaha.122.319951 · Cited by 790
The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
Attems, J., & Jellinger, K. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0206-2 · Cited by 739
“SVD-induced ApoE leakage was associated with AD and accumulation of β-amyloid (Aβ) in perivascular astrocytes [61] and transient induction of Aβ deposition [62].”
BackgroundVascular contributions to cognitive impairment and dementia including Alzheimer's disease
Snyder, H. M., Corriveau, R. A., Craft, S., Faber, J. E., Greenberg, S. M., Knopman, D., Lamb, B. T., Montine, T. J., Nedergaard, M., Schaffer, C. B., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.008 · Cited by 603
Self-citationEmerging concepts in sporadic cerebral amyloid angiopathy
Charidimou, A., Boulouis, G., Gurol, M. E., Ayata, C., Bacskai, B. J., Frosch, M. P., Viswanathan, A., & Greenberg, S. M. (2017) · Brain · doi:10.1093/brain/awx047 · Cited by 555
Self-citationTrajectory of Cognitive Decline After Incident Stroke
Levine, D. A., Galecki, A. T., Langa, K. M., Unverzagt, F. W., Kabeto, M. U., Giordani, B., & Wadley, V. G. (2015) · JAMA · doi:10.1001/jama.2015.6968 · Cited by 497
Kent, S. A., Spires-Jones, T. L., & Durrant, C. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02196-w · Cited by 446
Stroke and dementia risk: A systematic review and meta‐analysis
Kuźma, E., Lourida, I., Moore, S. F., Levine, D. A., Ukoumunne, O. C., & Llewellyn, D. J. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3061 · Cited by 376
Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease
Korte, N., Nortley, R., & Attwell, D. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02215-w · Cited by 350
Cardiovascular risk factors and future risk of Alzheimer’s disease
de Bruijn, R. F., & Ikram, M. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0130-5 · Cited by 322
The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
Brothers, H. M., Gosztyla, M. L., & Robinson, S. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00118 · Cited by 314
“Micro-hemorrhages created with Rose Bengal dye in transgenic-AD mice drove transient increases in Aß plaques in infarcted and adjacent areas (Garcia-Alloza et al., 2011).”
BackgroundInterstitial fluid drainage is impaired in ischemic stroke and Alzheimer’s disease mouse models
Arbel-Ornath, M., Hudry, E., Eikermann-Haerter, K., Hou, S., Gregory, J. L., Zhao, L., Betensky, R. A., Frosch, M. P., Greenberg, S. M., & Bacskai, B. J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1145-2 · Cited by 257
Self-citationModifiable Risk Factors for Alzheimer’s Disease
Edwards III, G. A., Gamez, N., Escobedo Jr., G., Calderon, O., & Moreno-Gonzalez, I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00146 · Cited by 253
“On the other hand, the main Aβ clearance mechanisms are altered and damaged under the presence of vascular dysfunction contributing to parenchymal and vascular accumulation of Aβ (Garcia-Alloza et al., 2011).”
BackgroundNeurovascular Unit Dysfunction and Neurodegenerative Disorders
Yu, X., Ji, C., & Shao, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00334 · Cited by 244
The Relationship between Obstructive Sleep Apnea and Alzheimer’s Disease
Andrade, A. G., Bubu, O. M., Varga, A. W., & Osorio, R. S. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179936 · Cited by 216
“It has been proposed that cerebrovascular disease could directly promote A (cid:2) production and reduce its clearance [154, 155]; however, available data on this hypothesis is still inconsistent [155, 156].”
Morris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212
Fibrinogen and Altered Hemostasis in Alzheimer's Disease
Cortes-Canteli, M., Zamolodchikov, D., Ahn, H. J., Strickland, S., & Norris, E. H. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120820 · Cited by 181
Amyloid‐β immunotherapy for alzheimer disease: Is it now a long shot?
Panza, F., Lozupone, M., Seripa, D., & Imbimbo, B. P. (2019) · Annals of Neurology · doi:10.1002/ana.25410 · Cited by 178
Early-onset and delayed-onset poststroke dementia — revisiting the mechanisms
Mok, V. C. T., Lam, B. Y. K., Wong, A., Ko, H., Markus, H. S., & Wong, L. K. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.16 · Cited by 158
Ischemic brain injury in cerebral amyloid angiopathy
Reijmer, Y. D., van Veluw, S. J., & Greenberg, S. M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.88 · Cited by 145
Self-citationVascular Aspects of Cognitive Impairment and Dementia
Wiesmann, M., Kiliaan, A. J., & Claassen, J. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.159 · Cited by 143
Levine, D. A., Wadley, V. G., Langa, K. M., Unverzagt, F. W., Kabeto, M. U., Giordani, B., Howard, G., Howard, V. J., Cushman, M., Judd, S. E., et al. (2018) · Stroke · doi:10.1161/strokeaha.117.018529 · Cited by 140
Goulay, R., Romo, L. M., Hol, E. M., & Dijkhuizen, R. M. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00755-2 · Cited by 159
Wang, H., Zhang, M., Li, J., Liang, J., Yang, M., Xia, G., Ren, Y., Zhou, H., Wu, Q., He, Y., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02435-9 · Cited by 133
Tan, X.-L., Xue, Y.-Q., Ma, T., Wang, X., Li, J. J., Lan, L., Malik, K. U., McDonald, M. P., Dopico, A. M., & Liao, F.-F. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0020-0 · Cited by 129
Rapid β-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 Mice
Ramos-Rodriguez, J. J., Pacheco-Herrero, M., Thyssen, D., Murillo-Carretero, M. I., Berrocoso, E., Spires-Jones, T. L., Bacskai, B. J., & Garcia-Alloza, M. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318288a8dd · Cited by 125
Self-citationCan we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease
Carrillo, M. C., Brashear, H. R., Logovinsky, V., Ryan, J. M., Feldman, H. H., Siemers, E. R., Abushakra, S., Hartley, D. M., Petersen, R. C., Khachaturian, A. S., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.12.004 · Cited by 124
Genome instability in Alzheimer disease
Hou, Y., Song, H., Croteau, D. L., Akbari, M., & Bohr, V. A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.04.005 · Cited by 120
Zhang, X., Yin, X., Zhang, J., Li, A., Gong, H., Luo, Q., Zhang, H., Gao, Z., & Jiang, H. (2019) · National Science Review · doi:10.1093/nsr/nwz124 · Cited by 122
Endothelin-1 is Elevated in Alzheimer's Disease and Upregulated by Amyloid-β
Palmer, J. C., Barker, R., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111760 · Cited by 110
Vascular Hypothesis of Alzheimer Disease: Topical Review of Mouse Models
Scheffer, S., Hermkens, D. M. A., van der Weerd, L., de Vries, H. E., & Daemen, M. J. A. P. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.311911 · Cited by 102
Nalivaeva, N. N., Belyaev, N. D., Kerridge, C., & Turner, A. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00235 · Cited by 104
Different microvascular alterations underlie microbleeds and microinfarcts
van Veluw, S. J., Scherlek, A. A., Freeze, W. M., ter Telgte, A., van der Kouwe, A. J., Bacskai, B. J., Frosch, M. P., & Greenberg, S. M. (2019) · Annals of Neurology · doi:10.1002/ana.25512 · Cited by 104
“A possible explanation for this observation could be that the extensive Aβ buildup in vessels surrounding an ischemic area is the result of impaired paravascular clearance of solutes, including Aβ, that occurs after vessel occlusions.(25,26) However, in our study we also found increased numbers of Aβ-positive cortical…”
ResultSelf-citationCerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?
Silva, T. M. D., & Miller, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00061 · Cited by 112
A clinical primer for the glymphatic system
Carlstrom, L. P., Eltanahy, A. M., Perry, A., Rabinstein, A. A., Elder, B. D., Morris, J. M., Meyer, F. B., Graffeo, C. S., Lundgaard, I., & Burns, T. C. (2021) · Brain · doi:10.1093/brain/awab428 · Cited by 107
Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β‐amyloid
Maki, T., Okamoto, Y., Carare, R. O., Hase, Y., Hattori, Y., Hawkes, C. A., Saito, S., Yamamoto, Y., Terasaki, Y., Ishibashi‐Ueda, H., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.79 · Cited by 99
Functional deficits induced by cortical microinfarcts
Summers, P. M., Hartmann, D. A., Hui, E. S. K., Nie, X., Deardorff, R. L., McKinnon, E. T., Helpern, J. A., Jensen, J. H., & Shih, A. Y. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16685573 · Cited by 101
Sams‐Dodd, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.10.010 · Cited by 97
The Pathophysiology and Clinical Presentation of Cerebral Amyloid Angiopathy
Auriel, E., & Greenberg, S. M. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0254-z · Cited by 96
Self-citationThe early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 85
Wu, Y., Bogale, T. A., Koıstınaho, J., Pizzi, M., Rõlova, T., & Bellucci, A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02696-z · Cited by 91
Preventing Alzheimer's Disease by Targeting Vascular Risk Factors: Hope and Gap
Qiu, C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120922 · Cited by 78
Chronic cerebral hypoperfusion induces post-stroke dementia following acute ischemic stroke in rats
Back, D. B., Kwon, K. J., Choi, D.-H., Shin, C. Y., Lee, J., Han, S., & Kim, H. Y. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0992-5 · Cited by 87
New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Saito, S., & Ihara, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00290 · Cited by 73
Yu, W., Li, Y., Hu, J. P., Wu, J., & Huang, Y. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164742 · Cited by 82
Lim, J., Lee, J., & Woo, C. (2021) · Journal of Stroke · doi:10.5853/jos.2021.02376 · Cited by 83
Javanshiri, K., Waldö, M. L., Friberg, N., Sjövall, F., Wickerström, K., Haglund, M., & Englund, E. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180644 · Cited by 80
Cerebral white matter lesions – associations with Aβ isoforms and amyloid PET
van Westen, D., Lindqvist, D., Blennow, K., Minthon, L., Nägga, K., Stomrud, E., Zetterberg, H., & Hansson, O. (2016) · Scientific Reports · doi:10.1038/srep20709 · Cited by 66
Animal models of cerebral amyloid angiopathy
Jäkel, L., Van Nostrand, W. E., Nicoll, J. A. R., Werring, D. J., & Verbeek, M. M. (2017) · Clinical Science · doi:10.1042/cs20170033 · Cited by 70
Yu, J. H., Han, K., Park, S. H., Cho, H., Lee, D. Y., Kim, J. W., Seo, J. A., Kim, S. G., Baik, S. H., Park, Y. G., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0216 · Cited by 77
Effects of the PPAR- α Agonist Fenofibrate on Acute and Short-Term Consequences of Brain Ischemia
Ouk, T., Gautier, S., Pétrault, M., Montaigne, D., Maréchal, X., Masse, I., Devedjian, J.-C., Deplanque, D., Bastide, M., Nevière, R., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.233 · Cited by 75
Ramos‐Rodríguez, J. J., Jiménez-Palomares, M., Murillo-Carretero, M. I., Infante‐Garcia, C., Berrocoso, E., Pacho, F. H., Lechuga-Sancho, A. M., Cózar‐Castellano, I., & García-Alloza, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.606 · Cited by 72
Bales, K. R., O’Neill, S. M., Pozdnyakov, N., Pan, F., Caouette, D., Pi, Y., Wood, K. M., Volfson, D., Cirrito, J. R., Han, B.-H., et al. (2016) · Brain · doi:10.1093/brain/awv313 · Cited by 68
“…CAA is almost always evident in brain tissue from subjects with sporadic late onset Alzheimer's disease and also contributes to other brain injuries such as ischaemic stroke and intracerebral haemorrhage (Jellinger, 2002; Weller and Nicoll, 2003; Kimberly et al., 2009; Garcia-Alloza et al., 2011).”
Cerebrovascular Disease, Amyloid Plaques, and Dementia
Liu, W., Wong, A., Law, A. C. K., & Mok, V. (2015) · Stroke · doi:10.1161/strokeaha.114.006571 · Cited by 76
Infante‐Garcia, C., Ramos‐Rodríguez, J. J., Galindo-Gonzalez, L., & García-Alloza, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.12.001 · Cited by 71
Ye, X., Wang, M., Zhang, W., Bai, M., Du, Y., Zhang, Z., Li, Z., & Miao, J. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.11.016 · Cited by 72
RetractedPrediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice
Ramos‐Rodríguez, J. J., Ortiz-Barajas, O., Gamero-Carrasco, C., de la Rosa, P. R., Infante‐Garcia, C., Zopeque-Garcia, N., Lechuga-Sancho, A. M., & García-Alloza, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.005 · Cited by 64
Association between atherosclerosis and Alzheimer's disease: A systematic review and meta‐analysis
Xie, B.-J., Shi, X.-R., Xing, Y., & Tang, Y. (2020) · Brain and Behavior · doi:10.1002/brb3.1601 · Cited by 53
Martínez, G., Vernooij, R. W., Fuentes Padilla, P., Zamora, J., Bonfill Cosp, X., & Flicker, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012216.pub2 · Cited by 59
Buckley, R. F., The Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group, Ellis, K. A., Ames, D., Rowe, C. C., Lautenschlager, N. T., Maruff, P., Villemagne, V. L., Macaulay, S. L., Szoeke, C., et al. (2015) · Neuropsychology · doi:10.1037/neu0000156 · Cited by 56
Martínez, G., Vernooij, R. W., Fuentes Padilla, P., Zamora, J., Flicker, L., & Bonfill Cosp, X. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012884 · Cited by 54
Rodent Models of Cerebral Microinfarct and Microhemorrhage
Shih, A. Y., Hyacinth, H. I., Hartmann, D. A., & van Veluw, S. J. (2018) · Stroke · doi:10.1161/strokeaha.117.016995 · Cited by 52
Ramos-Rodriguez, J. J., Molina-Gil, S., Rey-Brea, R., Berrocoso, E., & Garcia-Alloza, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079947 · Cited by 46
In Vivo Imaging of Microglia With Multiphoton Microscopy
Hierro-Bujalance, C., Bacskai, B. J., & Garcia-Alloza, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00218 · Cited by 46
Self-citationSanchez‐Bezanilla, S., Hood, R. J., Collins‐Praino, L. E., Turner, R. J., Walker, F. R., Nilsson, M., & Ong, L. K. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211005877 · Cited by 54
Sankar, S. B., Infante-Garcia, C., Weinstock, L. D., Ramos-Rodriguez, J. J., Hierro-Bujalance, C., Fernandez-Ponce, C., Wood, L. B., & Garcia-Alloza, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1707-x · Cited by 46
Alzheimer’s Disease: Drug Discovery
(2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020 · Cited by 44
Martínez, G., Vernooij, R. W. M., Padilla, P. F., Zamora, J., Flicker, L. A., & Bonfill, X. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012883 · Cited by 54
Zuliani, G., Trentini, A., Rosta, V., Guerrini, R., Pacifico, S., Bonazzi, S., Guiotto, A., Passaro, A., Seripa, D., Valacchi, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72168-3 · Cited by 46
White Matter Hyperintensities are associated with Amyloid Burden in APOE4 Non-Carriers
Noh, Y., Seo, S. W., Jeon, S., Lee, J. M., Kim, J.-H., Kim, G. H., Cho, H., Yoon, C. W., Kim, H. J., Ye, B. S., et al. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130461 · Cited by 42
Ramos‐Rodríguez, J. J., Infante‐Garcia, C., Galindo-Gonzalez, L., Garcia-Molina, Y., Lechuga-Sancho, A. M., & García-Alloza, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9311-2 · Cited by 47
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes
Miners, J. S., Palmer, J. C., Tayler, H. M., Palmer, L. E., Ashby, E. L., Kehoe, P. G., & Love, S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00238 · Cited by 50
Intracerebral hemorrhage and cognitive impairment
Xiong, L., Reijmer, Y. D., Charidimou, A., Cordonnier, C., & Viswanathan, A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.011 · Cited by 55
Dowling, N. M., Johnson, S., & Nadareishvili, Z. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033807 · Cited by 53
Is Cerebral Amyloid-β Deposition Related to Post-stroke Cognitive Impairment?
Ouyang, F., Jiang, Z., Chen, X., Chen, Y., Wei, J., Xing, S., Zhang, J., Fan, Y., & Zeng, J. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00921-5 · Cited by 43
Jo, W. K., Law, A. C. K., & Chung, S. K. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.171 · Cited by 53
Sahathevan, R., Linden, T. K. A., Villemagne, V. L., Churilov, L. P., Ly, J. V., Rowe, C. C., Donnan, G. A., & Brodtmann, A. G. (2015) · Stroke · doi:10.1161/strokeaha.115.010528 · Cited by 49
Infante‐Garcia, C., Ramos‐Rodríguez, J. J., Hierro‐Bujalance, C., Ortegon, E., Pickett, E. K., Jackson, R. J., Pacho, F. H., Spires‐Jones, T. L., & García-Alloza, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0825-7 · Cited by 43
On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications
Inyushin, M. Y., Zayas‐Santiago, A., Rojas, L. V., & Kucheryavykh, L. Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571083 · Cited by 45
Cerebral amyloid angiopathy impact on endothelium
Grinberg, L. T., Korczyn, A. D., & Heinsen, H. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.08.005 · Cited by 39
Glymphatic System Dysfunction in Central Nervous System Diseases and Mood Disorders
Zhang, D., Li, X., & Li, B. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.873697 · Cited by 49
Howe, M. D., Atadja, L. A., Furr, J. W., Maniskas, M. E., Zhu, L., McCullough, L. D., & Urayama, A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.019 · Cited by 36
Peres, R., De Guio, F., Chabriat, H., & Jouvent, E. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15625352 · Cited by 36
Alzheimer's Disease—Current Status and Future Directions
Bhardwaj, D., Mitra, C., Narasimhulu, C. A., Riad, A., Doomra, M., & Parthasarathy, S. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2017.0093 · Cited by 39
Nguyen, T. V., Hayes, M. I., Zbesko, J. C., Frye, J. B., Congrove, N. R., Belichenko, N. P., McKay, B. S., Longo, F. M., & Doyle, K. P. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0603-4 · Cited by 37
IMAGING VASCULAR DISEASE AND AMYLOID IN THE AGING BRAIN: IMPLICATIONS FOR TREATMENT
Villeneuve, S., & Jagust, W. J. (2015) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2015.47 · Cited by 39
Trends in cognitive function before and after stroke in China
Hua, J., Dong, J., Chen, G., & Shen, Y. (2023) · BMC Medicine · doi:10.1186/s12916-023-02908-5 · Cited by 38
Neurovascular dysfunction in dementia – human cellular models and molecular mechanisms
Parkes, I., Chintawar, S., & Cader, M. Z. (2018) · Clinical Science · doi:10.1042/cs20160720 · Cited by 35
AβPeptide Originated from Platelets Promises New Strategy in Anti-Alzheimer’s Drug Development
Inyushin, M. Y., Sanabria, P., Rojas, L. V., Kucheryavykh, Y. V., & Kucheryavykh, L. Y. (2017) · BioMed Research International · doi:10.1155/2017/3948360 · Cited by 32
Development of a Multicomponent Intervention to Prevent Alzheimer's Disease
Saitô, S., Yamamoto, Y., & Ihara, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00490 · Cited by 31
Hagberg, G., Ihle‐Hansen, H., Fure, B., Thommessen, B., Ihle‐Hansen, H., Øksengård, A. R., Beyer, M. K., Wyller, T. B., Müller, E. G., Pendlebury, S. T., et al. (2020) · BMC Neurology · doi:10.1186/s12883-020-01753-w · Cited by 35
Shared pathophysiology: Understanding stroke and Alzheimer’s disease
Sriram, S., Mehkri, Y., Quintin, S. S., & Lucke-Wold, B. P. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107306 · Cited by 29
Lorrio, S., Gómez‐Rangel, V., Negredo, P., Egea, J., Leon, R. M., Romero, A., Dal-Cim, T. A., Villarroya, M., Rodríguez-Franco, M. I., Conde, S., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.001 · Cited by 33
Zhang, Q., Stafford, R. B., Wang, Z., Arnold, S. E., Wolk, D. A., & Detre, J. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120964 · Cited by 32
The Role of Cerebrovascular Disease in Amyloid Deposition
Noh, Y., Seo, S. W., Jeon, S., Lee, J. M., Kim, J. S., Lee, J., Kim, J., Kim, G. H., Ye, B. S., Cho, H., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150832 · Cited by 29
Sanchez‐Bezanilla, S., TeBay, C., Nilsson, M., Walker, F. R., & Ong, L. K. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.05.001 · Cited by 29
Metadata
- Authors
- Garcia-Alloza, M., Gregory, J., Kuchibhotla, K. V., Fine, S., Wei, Y., Ayata, C., Frosch, M. P., Greenberg, S. M., & Bacskai, B. J.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-11-26
- Volume
- 134
- Issue
- 12
- Pages
- 3697-3707
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3235567
- OpenAlex
- W2121469208
- Cited by
- 187
- References
- 69
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 11 · 2023: 8 · 2022: 7 · 2021: 21 · 2020: 13 · 2019: 13 · 2018: 14 · 2017: 17 · 2016: 9 · 2015: 15 · 2014: 17 · 2013: 9 · 2012: 10
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute on Aging (AG005134, R01AG021084, AG021084, P50AG005134)
- National Institute of Biomedical Imaging and Bioengineering (EB-00768, R01EB000768)
- National Center for Research Resources (S10RR025645)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- cerebrovascular disease, amyloid-beta deposition, Alzheimer's disease, cerebral infarction, amyloid plaques, amyloid angiopathy, middle cerebral artery occlusion, amyloid clearance, APP/PS1 mice, rose bengal, multiphoton microscopy
- MeSH terms
- Alzheimer Disease, Animals, Brain, Brain Ischemia, Humans, Insulysin, Neurons, Neprilysin, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Stroke, Mice, Presenilin-1, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.